Zhaoye Qian
Huai'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Irinotecan with trifluridine/tipiracil and bevacizumab for second-line metastatic colorectal cancer: a phase II multicenter study.
Journal: Signal transduction and targeted therapy
Published: April 26, 2025
Combining iRGD with HuFOLactis enhances antitumor potency by facilitating immune cell infiltration and activation.
Journal: Human vaccines & immunotherapeutics
Published: August 05, 2024
Mycobacterium smegmatis enhances shikonin-induced immunogenic cell death-an efficient in situ tumor vaccine strategy.
Journal: Journal of biomedical research
Published: May 29, 2024
Efficacy of MAGE-A4 long peptide as a universal immunoprevention cancer vaccine.
Journal: Cancer cell international
Published: January 03, 2024
miR‑142‑5p inhibits pancreatic cancer cell migration and invasion by targeting PIK3CA.
Journal: Molecular medicine reports
Published: February 13, 2019
miR-142-5p regulates pancreatic cancer cell proliferation and apoptosis by regulation of RAP1A.
Journal: Pathology, research and practice
Published: February 11, 2019
Intronic polymorphisms in genes LRFN2 (rs2494938) and DNAH11 (rs2285947) are prognostic indicators of esophageal squamous cell carcinoma.
Journal: BMC medical genetics
Published: December 29, 2018
Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment.
Journal: International journal of nanomedicine
Published: September 22, 2017
Combination of histoculture drug response assay and qPCR as an effective method to screen biomarkers for personalized chemotherapy in esophageal cancer.
Journal: Oncology letters
Published: April 12, 2016
Effects of JWA, XRCC1 and BRCA1 mRNA expression on molecular staging for personalized therapy in patients with advanced esophageal squamous cell carcinoma.
Journal: BMC cancer
Published: August 18, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026